New York -- An unprecedented and ambitious sharing of data on Alzheimer's disease has led to advances in diagnosis and treatment, health experts say.
It is the end result of an effort begun in 2003 by scientists and executives from the National Institutes of Health, the Food and Drug Administration, the drug and medical-imaging industries, universities and non-profit groups, The New York Times reported Friday.
The goal was to find and identify the biological markers that reveal the progression of the disease in the human brain.
The key to the project was an agreement to share all the data so anyone with a computer anywhere in the world would have full and immediate access to the findings, the newspaper said.